A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Local Institution - 0009, A Coruña

Local Institution - 0022, Granada

Local Institution - 0029, Milan

Local Institution - 0013, Durham

Local Institution - 0010, Majadahonda

Local Institution - 0008, Málaga

Local Institution - 0002, El Palmar

Local Institution - 0027, Bologna

Local Institution - 0031, Cincinnati

Local Institution - 0003, Valencia

Local Institution - 0005, Florence

Local Institution - 0006, Salt Lake City

Local Institution - 0014, Los Angeles

Local Institution - 0026, La Jolla

Local Institution - 0016, San Francisco

Local Institution - 0001, Kansas City

Local Institution - 0032, New York

Local Institution - 0015, Cleveland

Local Institution - 0024, Portland

Local Institution - 0021, Nashville

Local Institution - 0025, San Antonio

Local Institution - 0011, Katowice

Local Institution - 0030, Wroclaw

Local Institution - 0028, Alicante

Local Institution - 0023, Barcelona